Allogene Therapeutics (ALLO) Times Interest Earned (2018 - 2026)
Allogene Therapeutics (ALLO) reported Times Interest Earned of -$0.45 for Q1 2026, up 90.31% on a YoY basis from -$0.24 in Q1 2025, and up 99.67% sequentially from -$135.48 in Q4 2025.
Allogene Therapeutics (ALLO) Times Interest Earned (2018 - 2026) Analysis & Trends
Allogene Therapeutics (ALLO) has 9 years of Times Interest Earned data on file, last reported at -$0.45 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 90.31% year-over-year to -$0.45; the trailing twelve-month figure through Mar 2026 stood at -$1.85 (up 90.3% YoY), and the FY2025 full-year result was -$16.23, down 2541.71% from the prior year.
- Times Interest Earned grew to -$0.45 in Q1 2026, from -$135.48 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $14.18 in Q4 2023 to a low of -$746.79 in Q4 2024.
- A 5-year average of -$57.77 and a median of -$2.33 in 2022 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 201.54% in 2023 and tumbled 5364.71% in 2024, its largest moves.
- Tracing ALLO's Times Interest Earned over 5 years: stood at -$13.97 in 2022, then soared by 201.54% to $14.18 in 2023, then plunged by 5364.71% to -$746.79 in 2024, then jumped by 81.86% to -$135.48 in 2025, then soared by 99.67% to -$0.45 in 2026.
- Business Quant data shows ALLO's Times Interest Earned at -$0.45 in Q1 2026, -$135.48 in Q4 2025, and -$1.85 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Allogene Therapeutics | 437.33 Mn | 437.33 Mn | - | -0.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.45 |
| Dec 31, 2025 | -135.48 |
| Sep 30, 2025 | -1.85 |
| Jun 30, 2025 | -2.22 |
| Mar 31, 2025 | -4.63 |
| Dec 31, 2024 | -746.79 |
| Sep 30, 2024 | -5.27 |
| Jun 30, 2024 | -0.57 |
| Mar 31, 2024 | -5.11 |
| Dec 31, 2023 | 14.18 |
| Sep 30, 2023 | -1.81 |
| Jun 30, 2023 | -2.22 |
| Mar 31, 2023 | -33.03 |
| Dec 31, 2022 | -13.97 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -2.33 |
| Mar 31, 2022 | -40.01 |
| Dec 31, 2021 | 0.90 |
| Sep 30, 2021 | -0.93 |
| Jun 30, 2021 | -0.93 |